Michael Weiser's Net Worth

$39 Million

Who is Michael Weiser?

Michael Weiser has an estimated net worth of $39 Million. This is based on reported shares across multiple companies, which include IOVANCE BIOTHERAPEUTICS, INC., MANHATTAN PHARMACEUTICALS INC, EMISPHERE TECHNOLOGIES INC, ZIOPHARM ONCOLOGY INC, Hana Biosciences Inc, VioQuest Pharmaceuticals, Inc., Innovive Pharmaceuticals, Inc., KANAI SCIENCES, INC., SEWARD SCIENCES, INC., KODIAK SCIENCES, INC., Paramount Acquisition Corp, IVORY CAPITAL CORP, and Chelsea Therapeutics International, Ltd..

SEC CIK

Michael Weiser's CIK is 0001221449

Past Insider Trading and Trends

2006 was Michael Weiser's most active year for acquiring shares with 21 total transactions. Michael Weiser's most active month to acquire stocks was the month of December. 2014 was Michael Weiser's most active year for disposing of shares, totalling 15 transactions. Michael Weiser's most active month to dispose stocks was the month of May. 2014 saw Michael Weiser paying a total of $178,750.00 for 120,000 shares, this is the most they've acquired in one year. In 2008 Michael Weiser cashed out on 13,931.57 shares for a total of $2,631,000.00, their largest year based on trade value.